"St Pancras Clinical Research is a leading independent clinical research company specialising in Alzheimer's Disease, chronic pain conditions and diabetes clinical trials."

During the past decade, St Pancras Clinical Research conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 3 clinical trials were completed, i.e. on average, 27.3% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 3 clinical trials were completed. i.e. 37.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St Pancras Clinical Research" #1 sponsor was "Eisai Inc." with 2 trials, followed by "Alzheon Inc." with 1 trials sponsored, "Biogen" with 1 trials sponsored, "Bone Therapeutics S.A" with 1 trials sponsored and "COMPASS Pathways" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St Pancras Clinical Research" #1 collaborator was "Biogen" with 2 trials as a collaborator, "National Institute on Aging (NIA)" with 2 trials as a collaborator, "Alzheimer's Clinical Trials Consortium" with 1 trials as a collaborator, "Amsterdam UMC, location VUmc" with 1 trials as a collaborator and "Nordic Bioscience A/S" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "St Pancras Clinical Research" are "Early Alzheimer's Disease" (2 trials), "Allergic Rhinitis" (1 trials), "Alzheimer Disease" (1 trials), "BCCs in Gorlin Syndrome Patients" (1 trials) and "Chronic Scar Pain" (1 trials). Many other conditions were trialed in "St Pancras Clinical Research" in a lesser frequency.

Most popular intervention types in "St Pancras Clinical Research" are "Drug" (11 trials), "Other" (2 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Lecanemab" (2 trials), "placebo" (2 trials), "BIIB074" (1 trials) and "Botulinum toxin type A" (1 trials). Other intervention names were less common.

The vast majority of trials in "St Pancras Clinical Research" are 11 trials for "All" genders.

Currently, there are NaN active trials in "St Pancras Clinical Research". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in St Pancras Clinical Research, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in St Pancras Clinical Research, 2 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".